Question: In patients with early or mild stage Alzheimer’s dementia how effective is memantine when compared to standard care in slowing the progression of dementia and/or delaying admittance to institutionalised care.

Answer:

The limited evidence currently available does not support the routine use of memantine to delay disease progression in patients with early or mild stage Alzheimer's dementia.

To view the full summary, click the Download Document link to the right.

To view relevant national guidelines, click Related Links, below.

To view the Cochrane review which is included in this summary, click Related Documents, below.